| Non-Clear Cell Renal Cell Carcinoma studied in …STUDIED_INderived62 of 62show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981509Phase 2 · recruiting Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04071223Phase 2 · active not recruiting Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07024680completed Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03635892Phase 2 · active not recruiting A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05831891Phase 2 · active not recruiting Fruquintinib Plus Serplulimab as First-Line Therapy for Metastatic Non-Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07816770Phase 2 · not yet recruiting MANTIS-RCC: Toripalimab-Axitinib Induction in TLS-Positive Advanced Non-Clear Cell and Renal Medullary Carcinomas · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05411081Phase 2 · active not recruiting Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03793166Phase 3 · active not recruiting Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03055013Phase 3 · active not recruiting Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776483not yet recruiting Personalized ctDNA Monitoring for Predicting Immunotherapy Outcomes in Advanced Non-Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620574Phase 3 · enrolling by invitation Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792552Phase 1 · recruiting A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176483Phase 1 · recruiting Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06866262Phase 1/Phase 2 · recruiting Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05665361Phase 1/Phase 2 · recruiting Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05678673Phase 3 · active not recruiting Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04413123Phase 2 · active not recruiting Cabozantinib In Combo With NIVO + IPI In Advanced NCCRCC · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06049576Phase 1 · active not recruiting Nivolumab and Ipilimumab With and Without Camu Camu for the Treatment of Patients With Metastatic Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541902Phase 2 · active not recruiting Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07128680Phase 1 · recruiting Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689240Phase 3 · not yet recruiting Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06339138completed Identification of Novel High Quality Methylated DNA Markers in Renal Tumors: Whole Methylome Discovery, Tissue Validation, and Feasibility Testing In Blood and Urine, The INQUIRE Study · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06447103Phase 2 · recruiting An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07037004Phase 2 · recruiting Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06026410Phase 1 · recruiting KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05043090Phase 3 · active not recruiting Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00898365completed Study of Kidney Tumors in Younger Patients · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06318871early Phase 1 · active not recruiting Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05808608Phase 1/Phase 2 · active not recruiting A Study of AK104 Plus Axitinib in Advanced/Metastatic Special Pathological Subtypes of Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07488533Phase 2 · active not recruiting Comparing the Combination of Sullumab and Fruquintinib in Postoperative Adjuvant Therapy for High Recurrence Risk Non Transparent Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05122546Phase 1 · active not recruiting CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07243067not yet recruiting Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04623502NA · recruiting An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07218692Phase 2 · not yet recruiting RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272034Phase 1 · terminated Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06805825Phase 1 · recruiting A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06683846Phase 2 · recruiting Ivonescimab in the Treatment of Multiple Advanced Tumors · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03685448Phase 2 · completed ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB) · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01767636Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02761057Phase 2 · completed Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05620134Phase 1/Phase 2 · active not recruiting Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399419Phase 1 · recruiting CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06146777Phase 3 · not yet recruiting Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00068393Phase 2 · completed Doxorubicin and Gemcitabine in Treating Patients With Locally Recurrent or Metastatic Unresectable Renal Cell Carcinoma · condition mapped ALIAS · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04603365Phase 2 · withdrawn Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Hereditary Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02915783Phase 2 · completed A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02489695Phase 2 · completed Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01664182Phase 2 · completed Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Sarcomatoid Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03177239Phase 2 · unknown Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02127710Phase 2 · completed A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) · condition mapped ALIAS · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02837991Phase 1 · terminated A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027820Phase 1/Phase 2 · completed Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005799NA · completed Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01688973Phase 2 · completed Tivantinib With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Locally Advanced Kidney Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01727089Phase 2 · completed Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Type 1 Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01108445Phase 2 · completed Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma · condition mapped CURATED_BROADER · 62 trials mapped (38 active) | — | — | Non-Clear Cell Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00335556Phase 2 · completed Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00126503Phase 1/Phase 2 · completed Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Chromophobe Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00098618Phase 2 · terminated Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer · condition mapped ONTOLOGY_EXACT · 62 trials mapped (38 active) | — | — | Papillary Renal Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |